
| NF-¦Ê¦¢ activator 1,2387524-59-4 | |||||||
| Cat.No.:IC-1080841 | |||||||
| Product Information | |||||||
| Biological Activity | |||||||
| NF-¦Ê¦¢ activater 1 (compound 32) is a potent NF-¦Ê¦¢ activator with EC50 of 0.9 ¦ÌM. NF-¦Ê¦¢ activater 1 induces superoxide dismutase (SOD)2 mRNA expression. | |||||||
| Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines) | |||||||
| Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog | |
| Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 | |
| Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 | |
| Km factor | 3 | 6 | 12 | 8 | 5 | 20 | |
| 
					Animal A (mg/kg) = Animal B (mg/kg) multiplied by  (Animal B Km / Animal A Km) | |||||||
| Chemical structure | Chemical Information | 
 | 
 | 
 | |||
| 
					 | M.Weight | 314.33 | |||||
| Formula | C16H11FN2O2S | ||||||
| CAS No. | 2387524-59-4 | ||||||
| Purity | >98.00% | ||||||
| Solubility | 100 mg/mL in DMSO | ||||||
| Storage | Keep in dark place,Inert atmosphere,2-8¡ãC | ||||||
| Reference | |||||||
| 1. Mathew B, et al. Structure-activity relationship (SAR) studies of N-(3-methylpyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine (SRI-22819) as NF-ҡB activators for the treatment of ALS [published online ahead of print, 2020 Oct 22]. Eur J Med Chem. 2020;112952. [Content Brief] | |||||||
| Order Information | 
 | 
 | |||||
| Cat./REF. | Size | Price($£© | Price(€) | Price(£¤/CNY£© | Price(£¤/JYP£© | ||
| IC-1080841 | 1mg | $119.40 | € 143.28 | £¤1,194.00 | £¤23,760.60 | ||
| IC-1080841 | 5mg | $298.30 | € 357.96 | £¤2,983.00 | £¤59,361.70 | ||
| IC-1080841 | 10mg | $481.90 | € 578.28 | £¤4,819.00 | £¤95,898.10 | ||
| 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
 | 
| We Devoted Ourselves To The Development Of Biomedical Research Reagent. | |||||||









